nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—prostate cancer—Hydrocortisone—systemic lupus erythematosus	0.228	0.388	CpDpCtD
Metoclopramide—CYP11B2—Hydrocortisone—systemic lupus erythematosus	0.16	0.469	CbGbCtD
Metoclopramide—prostate cancer—Dexamethasone—systemic lupus erythematosus	0.139	0.237	CpDpCtD
Metoclopramide—prostate cancer—Betamethasone—systemic lupus erythematosus	0.139	0.237	CpDpCtD
Metoclopramide—CYP11B1—Hydrocortisone—systemic lupus erythematosus	0.104	0.305	CbGbCtD
Metoclopramide—migraine—Prednisone—systemic lupus erythematosus	0.0809	0.138	CpDpCtD
Metoclopramide—CYP17A1—Dexamethasone—systemic lupus erythematosus	0.0646	0.189	CbGbCtD
Metoclopramide—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00762	0.0223	CbGbCtD
Metoclopramide—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00502	0.0147	CbGbCtD
Metoclopramide—CYP11B2—blood plasma—systemic lupus erythematosus	0.00152	0.214	CbGeAlD
Metoclopramide—Sunitinib—TYK2—systemic lupus erythematosus	0.000849	0.515	CrCbGaD
Metoclopramide—Sunitinib—BLK—systemic lupus erythematosus	0.000799	0.485	CrCbGaD
Metoclopramide—CYP2D6—urine—systemic lupus erythematosus	0.000515	0.0722	CbGeAlD
Metoclopramide—CYP17A1—connective tissue—systemic lupus erythematosus	0.000496	0.0696	CbGeAlD
Metoclopramide—CYP17A1—nephron tubule—systemic lupus erythematosus	0.00048	0.0674	CbGeAlD
Metoclopramide—CYP17A1—kidney—systemic lupus erythematosus	0.000422	0.0592	CbGeAlD
Metoclopramide—CYP17A1—cortex of kidney—systemic lupus erythematosus	0.000411	0.0577	CbGeAlD
Metoclopramide—DRD3—nervous system—systemic lupus erythematosus	0.000314	0.0441	CbGeAlD
Metoclopramide—DRD3—central nervous system—systemic lupus erythematosus	0.000303	0.0425	CbGeAlD
Metoclopramide—CYP17A1—nervous system—systemic lupus erythematosus	0.000277	0.0389	CbGeAlD
Metoclopramide—CYP2D6—blood plasma—systemic lupus erythematosus	0.000269	0.0377	CbGeAlD
Metoclopramide—CYP17A1—central nervous system—systemic lupus erythematosus	0.000267	0.0374	CbGeAlD
Metoclopramide—HTR3A—lung—systemic lupus erythematosus	0.000235	0.0329	CbGeAlD
Metoclopramide—HTR3A—nervous system—systemic lupus erythematosus	0.000217	0.0305	CbGeAlD
Metoclopramide—HTR3A—central nervous system—systemic lupus erythematosus	0.000209	0.0294	CbGeAlD
Metoclopramide—CHRM1—lung—systemic lupus erythematosus	0.000178	0.025	CbGeAlD
Metoclopramide—CHRM1—nervous system—systemic lupus erythematosus	0.000165	0.0232	CbGeAlD
Metoclopramide—CHRM1—central nervous system—systemic lupus erythematosus	0.000159	0.0223	CbGeAlD
Metoclopramide—DRD2—lung—systemic lupus erythematosus	0.000144	0.0202	CbGeAlD
Metoclopramide—Hypotension—Leflunomide—systemic lupus erythematosus	0.000137	0.00235	CcSEcCtD
Metoclopramide—Bradycardia—Triamcinolone—systemic lupus erythematosus	0.000136	0.00232	CcSEcCtD
Metoclopramide—Bradycardia—Methylprednisolone—systemic lupus erythematosus	0.000136	0.00232	CcSEcCtD
Metoclopramide—Nervousness—Cyclosporine—systemic lupus erythematosus	0.000135	0.0023	CcSEcCtD
Metoclopramide—Visual disturbance—Methotrexate—systemic lupus erythematosus	0.000135	0.0023	CcSEcCtD
Metoclopramide—Muscle spasms—Cyclosporine—systemic lupus erythematosus	0.000134	0.00228	CcSEcCtD
Metoclopramide—Insomnia—Leflunomide—systemic lupus erythematosus	0.000133	0.00227	CcSEcCtD
Metoclopramide—DRD2—nervous system—systemic lupus erythematosus	0.000133	0.0187	CbGeAlD
Metoclopramide—Hallucination—Methylprednisolone—systemic lupus erythematosus	0.000133	0.00226	CcSEcCtD
Metoclopramide—Nervousness—Mycophenolate mofetil—systemic lupus erythematosus	0.000132	0.00225	CcSEcCtD
Metoclopramide—Dyspnoea—Leflunomide—systemic lupus erythematosus	0.000131	0.00224	CcSEcCtD
Metoclopramide—Muscle spasms—Mycophenolate mofetil—systemic lupus erythematosus	0.00013	0.00223	CcSEcCtD
Metoclopramide—Tremor—Cyclosporine—systemic lupus erythematosus	0.00013	0.00222	CcSEcCtD
Metoclopramide—Visual impairment—Methylprednisolone—systemic lupus erythematosus	0.000129	0.00219	CcSEcCtD
Metoclopramide—Feeling abnormal—Azathioprine—systemic lupus erythematosus	0.000128	0.00219	CcSEcCtD
Metoclopramide—DRD2—central nervous system—systemic lupus erythematosus	0.000128	0.018	CbGeAlD
Metoclopramide—Agitation—Cyclosporine—systemic lupus erythematosus	0.000128	0.00218	CcSEcCtD
Metoclopramide—Tremor—Mycophenolate mofetil—systemic lupus erythematosus	0.000127	0.00217	CcSEcCtD
Metoclopramide—Angioedema—Cyclosporine—systemic lupus erythematosus	0.000127	0.00217	CcSEcCtD
Metoclopramide—Fatigue—Leflunomide—systemic lupus erythematosus	0.000127	0.00216	CcSEcCtD
Metoclopramide—Agitation—Mycophenolate mofetil—systemic lupus erythematosus	0.000125	0.00213	CcSEcCtD
Metoclopramide—Leukopenia—Cyclosporine—systemic lupus erythematosus	0.000124	0.00212	CcSEcCtD
Metoclopramide—Angioedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000124	0.00212	CcSEcCtD
Metoclopramide—Bradycardia—Dexamethasone—systemic lupus erythematosus	0.000123	0.00211	CcSEcCtD
Metoclopramide—Bradycardia—Betamethasone—systemic lupus erythematosus	0.000123	0.00211	CcSEcCtD
Metoclopramide—Neutropenia—Prednisone—systemic lupus erythematosus	0.000123	0.00211	CcSEcCtD
Metoclopramide—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000123	0.0021	CcSEcCtD
Metoclopramide—CYP2D6—kidney—systemic lupus erythematosus	0.000122	0.0171	CbGeAlD
Metoclopramide—Erectile dysfunction—Prednisone—systemic lupus erythematosus	0.000122	0.00207	CcSEcCtD
Metoclopramide—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000121	0.00207	CcSEcCtD
Metoclopramide—Feeling abnormal—Leflunomide—systemic lupus erythematosus	0.000121	0.00207	CcSEcCtD
Metoclopramide—Hallucination—Betamethasone—systemic lupus erythematosus	0.000121	0.00206	CcSEcCtD
Metoclopramide—Hallucination—Dexamethasone—systemic lupus erythematosus	0.000121	0.00206	CcSEcCtD
Metoclopramide—Convulsion—Cyclosporine—systemic lupus erythematosus	0.00012	0.00206	CcSEcCtD
Metoclopramide—Hypertension—Cyclosporine—systemic lupus erythematosus	0.00012	0.00205	CcSEcCtD
Metoclopramide—Palpitations—Mycophenolate mofetil—systemic lupus erythematosus	0.00012	0.00205	CcSEcCtD
Metoclopramide—Anxiety—Cyclosporine—systemic lupus erythematosus	0.000118	0.00201	CcSEcCtD
Metoclopramide—Convulsion—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.00201	CcSEcCtD
Metoclopramide—Depression—Prednisone—systemic lupus erythematosus	0.000117	0.002	CcSEcCtD
Metoclopramide—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.000117	0.002	CcSEcCtD
Metoclopramide—Visual impairment—Dexamethasone—systemic lupus erythematosus	0.000117	0.00199	CcSEcCtD
Metoclopramide—Visual impairment—Betamethasone—systemic lupus erythematosus	0.000117	0.00199	CcSEcCtD
Metoclopramide—Urticaria—Leflunomide—systemic lupus erythematosus	0.000117	0.00199	CcSEcCtD
Metoclopramide—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000116	0.00198	CcSEcCtD
Metoclopramide—Angioedema—Prednisolone—systemic lupus erythematosus	0.000116	0.00197	CcSEcCtD
Metoclopramide—Anxiety—Mycophenolate mofetil—systemic lupus erythematosus	0.000115	0.00196	CcSEcCtD
Metoclopramide—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.000115	0.00196	CcSEcCtD
Metoclopramide—Confusional state—Cyclosporine—systemic lupus erythematosus	0.000114	0.00195	CcSEcCtD
Metoclopramide—Oedema—Cyclosporine—systemic lupus erythematosus	0.000113	0.00194	CcSEcCtD
Metoclopramide—Angioedema—Hydrocortisone—systemic lupus erythematosus	0.000113	0.00193	CcSEcCtD
Metoclopramide—Confusional state—Mycophenolate mofetil—systemic lupus erythematosus	0.000112	0.00191	CcSEcCtD
Metoclopramide—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000111	0.00189	CcSEcCtD
Metoclopramide—Asthma—Methotrexate—systemic lupus erythematosus	0.00011	0.00188	CcSEcCtD
Metoclopramide—Convulsion—Prednisolone—systemic lupus erythematosus	0.00011	0.00187	CcSEcCtD
Metoclopramide—Hypertension—Prednisolone—systemic lupus erythematosus	0.000109	0.00186	CcSEcCtD
Metoclopramide—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000108	0.00185	CcSEcCtD
Metoclopramide—Tachycardia—Mycophenolate mofetil—systemic lupus erythematosus	0.000108	0.00184	CcSEcCtD
Metoclopramide—Bradycardia—Prednisone—systemic lupus erythematosus	0.000108	0.00184	CcSEcCtD
Metoclopramide—Convulsion—Hydrocortisone—systemic lupus erythematosus	0.000107	0.00183	CcSEcCtD
Metoclopramide—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.000107	0.00182	CcSEcCtD
Metoclopramide—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000107	0.00182	CcSEcCtD
Metoclopramide—Angioedema—Triamcinolone—systemic lupus erythematosus	0.000106	0.00181	CcSEcCtD
Metoclopramide—Angioedema—Methylprednisolone—systemic lupus erythematosus	0.000106	0.00181	CcSEcCtD
Metoclopramide—Asthenia—Leflunomide—systemic lupus erythematosus	0.000105	0.0018	CcSEcCtD
Metoclopramide—Hallucination—Prednisone—systemic lupus erythematosus	0.000105	0.00179	CcSEcCtD
Metoclopramide—Anxiety—Hydrocortisone—systemic lupus erythematosus	0.000105	0.00179	CcSEcCtD
Metoclopramide—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.000103	0.00177	CcSEcCtD
Metoclopramide—Oedema—Prednisolone—systemic lupus erythematosus	0.000103	0.00176	CcSEcCtD
Metoclopramide—Neutropenia—Methotrexate—systemic lupus erythematosus	0.000103	0.00176	CcSEcCtD
Metoclopramide—Dizziness—Azathioprine—systemic lupus erythematosus	0.000103	0.00176	CcSEcCtD
Metoclopramide—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000103	0.00175	CcSEcCtD
Metoclopramide—Erectile dysfunction—Methotrexate—systemic lupus erythematosus	0.000102	0.00173	CcSEcCtD
Metoclopramide—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.000101	0.00173	CcSEcCtD
Metoclopramide—Somnolence—Cyclosporine—systemic lupus erythematosus	0.000101	0.00172	CcSEcCtD
Metoclopramide—Oedema—Hydrocortisone—systemic lupus erythematosus	0.000101	0.00172	CcSEcCtD
Metoclopramide—Convulsion—Triamcinolone—systemic lupus erythematosus	0.000101	0.00172	CcSEcCtD
Metoclopramide—Tachycardia—Prednisolone—systemic lupus erythematosus	0.000101	0.00172	CcSEcCtD
Metoclopramide—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000101	0.00172	CcSEcCtD
Metoclopramide—Convulsion—Methylprednisolone—systemic lupus erythematosus	0.000101	0.00172	CcSEcCtD
Metoclopramide—Hypertension—Triamcinolone—systemic lupus erythematosus	0.0001	0.00171	CcSEcCtD
Metoclopramide—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.0001	0.00171	CcSEcCtD
Metoclopramide—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.0001	0.00171	CcSEcCtD
Metoclopramide—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	9.87e-05	0.00168	CcSEcCtD
Metoclopramide—Anxiety—Methylprednisolone—systemic lupus erythematosus	9.85e-05	0.00168	CcSEcCtD
Metoclopramide—Tachycardia—Hydrocortisone—systemic lupus erythematosus	9.84e-05	0.00168	CcSEcCtD
Metoclopramide—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	9.84e-05	0.00168	CcSEcCtD
Metoclopramide—Drowsiness—Methotrexate—systemic lupus erythematosus	9.83e-05	0.00168	CcSEcCtD
Metoclopramide—Rash—Azathioprine—systemic lupus erythematosus	9.82e-05	0.00168	CcSEcCtD
Metoclopramide—Dermatitis—Azathioprine—systemic lupus erythematosus	9.81e-05	0.00167	CcSEcCtD
Metoclopramide—Depression—Methotrexate—systemic lupus erythematosus	9.8e-05	0.00167	CcSEcCtD
Metoclopramide—Flushing—Prednisone—systemic lupus erythematosus	9.8e-05	0.00167	CcSEcCtD
Metoclopramide—Fatigue—Cyclosporine—systemic lupus erythematosus	9.78e-05	0.00167	CcSEcCtD
Metoclopramide—Headache—Azathioprine—systemic lupus erythematosus	9.75e-05	0.00166	CcSEcCtD
Metoclopramide—Dizziness—Leflunomide—systemic lupus erythematosus	9.72e-05	0.00166	CcSEcCtD
Metoclopramide—Angioedema—Betamethasone—systemic lupus erythematosus	9.65e-05	0.00165	CcSEcCtD
Metoclopramide—Angioedema—Dexamethasone—systemic lupus erythematosus	9.65e-05	0.00165	CcSEcCtD
Metoclopramide—Confusional state—Methylprednisolone—systemic lupus erythematosus	9.55e-05	0.00163	CcSEcCtD
Metoclopramide—Oedema—Triamcinolone—systemic lupus erythematosus	9.5e-05	0.00162	CcSEcCtD
Metoclopramide—Hypotension—Hydrocortisone—systemic lupus erythematosus	9.42e-05	0.00161	CcSEcCtD
Metoclopramide—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	9.35e-05	0.0016	CcSEcCtD
Metoclopramide—Insomnia—Prednisolone—systemic lupus erythematosus	9.34e-05	0.00159	CcSEcCtD
Metoclopramide—Rash—Leflunomide—systemic lupus erythematosus	9.27e-05	0.00158	CcSEcCtD
Metoclopramide—Tachycardia—Triamcinolone—systemic lupus erythematosus	9.27e-05	0.00158	CcSEcCtD
Metoclopramide—Dermatitis—Leflunomide—systemic lupus erythematosus	9.26e-05	0.00158	CcSEcCtD
Metoclopramide—Nausea—Azathioprine—systemic lupus erythematosus	9.25e-05	0.00158	CcSEcCtD
Metoclopramide—Tachycardia—Methylprednisolone—systemic lupus erythematosus	9.25e-05	0.00158	CcSEcCtD
Metoclopramide—Headache—Leflunomide—systemic lupus erythematosus	9.21e-05	0.00157	CcSEcCtD
Metoclopramide—Agranulocytosis—Methotrexate—systemic lupus erythematosus	9.17e-05	0.00157	CcSEcCtD
Metoclopramide—Convulsion—Dexamethasone—systemic lupus erythematosus	9.15e-05	0.00156	CcSEcCtD
Metoclopramide—Convulsion—Betamethasone—systemic lupus erythematosus	9.15e-05	0.00156	CcSEcCtD
Metoclopramide—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	9.12e-05	0.00156	CcSEcCtD
Metoclopramide—Insomnia—Hydrocortisone—systemic lupus erythematosus	9.12e-05	0.00156	CcSEcCtD
Metoclopramide—Hypertension—Dexamethasone—systemic lupus erythematosus	9.11e-05	0.00156	CcSEcCtD
Metoclopramide—Hypertension—Betamethasone—systemic lupus erythematosus	9.11e-05	0.00156	CcSEcCtD
Metoclopramide—Urticaria—Cyclosporine—systemic lupus erythematosus	9.01e-05	0.00154	CcSEcCtD
Metoclopramide—Body temperature increased—Cyclosporine—systemic lupus erythematosus	8.97e-05	0.00153	CcSEcCtD
Metoclopramide—Anxiety—Betamethasone—systemic lupus erythematosus	8.96e-05	0.00153	CcSEcCtD
Metoclopramide—Anxiety—Dexamethasone—systemic lupus erythematosus	8.96e-05	0.00153	CcSEcCtD
Metoclopramide—Hypotension—Methylprednisolone—systemic lupus erythematosus	8.85e-05	0.00151	CcSEcCtD
Metoclopramide—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	8.79e-05	0.0015	CcSEcCtD
Metoclopramide—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	8.75e-05	0.00149	CcSEcCtD
Metoclopramide—Nausea—Leflunomide—systemic lupus erythematosus	8.73e-05	0.00149	CcSEcCtD
Metoclopramide—Fatigue—Hydrocortisone—systemic lupus erythematosus	8.69e-05	0.00148	CcSEcCtD
Metoclopramide—Oedema—Betamethasone—systemic lupus erythematosus	8.62e-05	0.00147	CcSEcCtD
Metoclopramide—Oedema—Dexamethasone—systemic lupus erythematosus	8.62e-05	0.00147	CcSEcCtD
Metoclopramide—Insomnia—Triamcinolone—systemic lupus erythematosus	8.59e-05	0.00147	CcSEcCtD
Metoclopramide—Insomnia—Methylprednisolone—systemic lupus erythematosus	8.57e-05	0.00146	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisolone—systemic lupus erythematosus	8.51e-05	0.00145	CcSEcCtD
Metoclopramide—Visual impairment—Methotrexate—systemic lupus erythematosus	8.51e-05	0.00145	CcSEcCtD
Metoclopramide—Dyspnoea—Triamcinolone—systemic lupus erythematosus	8.47e-05	0.00144	CcSEcCtD
Metoclopramide—Agitation—Prednisone—systemic lupus erythematosus	8.45e-05	0.00144	CcSEcCtD
Metoclopramide—Tachycardia—Betamethasone—systemic lupus erythematosus	8.41e-05	0.00144	CcSEcCtD
Metoclopramide—Tachycardia—Dexamethasone—systemic lupus erythematosus	8.41e-05	0.00144	CcSEcCtD
Metoclopramide—Angioedema—Prednisone—systemic lupus erythematosus	8.4e-05	0.00143	CcSEcCtD
Metoclopramide—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	8.36e-05	0.00143	CcSEcCtD
Metoclopramide—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	8.31e-05	0.00142	CcSEcCtD
Metoclopramide—Urticaria—Prednisolone—systemic lupus erythematosus	8.2e-05	0.0014	CcSEcCtD
Metoclopramide—Fatigue—Triamcinolone—systemic lupus erythematosus	8.19e-05	0.0014	CcSEcCtD
Metoclopramide—Fatigue—Methylprednisolone—systemic lupus erythematosus	8.17e-05	0.00139	CcSEcCtD
Metoclopramide—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	8.16e-05	0.00139	CcSEcCtD
Metoclopramide—Asthenia—Cyclosporine—systemic lupus erythematosus	8.14e-05	0.00139	CcSEcCtD
Metoclopramide—Hypotension—Dexamethasone—systemic lupus erythematosus	8.05e-05	0.00137	CcSEcCtD
Metoclopramide—Hypotension—Betamethasone—systemic lupus erythematosus	8.05e-05	0.00137	CcSEcCtD
Metoclopramide—Urticaria—Hydrocortisone—systemic lupus erythematosus	8.01e-05	0.00137	CcSEcCtD
Metoclopramide—CYP2D6—nervous system—systemic lupus erythematosus	7.99e-05	0.0112	CbGeAlD
Metoclopramide—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	7.97e-05	0.00136	CcSEcCtD
Metoclopramide—Convulsion—Prednisone—systemic lupus erythematosus	7.97e-05	0.00136	CcSEcCtD
Metoclopramide—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	7.94e-05	0.00136	CcSEcCtD
Metoclopramide—Hypertension—Prednisone—systemic lupus erythematosus	7.94e-05	0.00135	CcSEcCtD
Metoclopramide—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	7.82e-05	0.00134	CcSEcCtD
Metoclopramide—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	7.81e-05	0.00133	CcSEcCtD
Metoclopramide—Anxiety—Prednisone—systemic lupus erythematosus	7.8e-05	0.00133	CcSEcCtD
Metoclopramide—Insomnia—Dexamethasone—systemic lupus erythematosus	7.79e-05	0.00133	CcSEcCtD
Metoclopramide—Insomnia—Betamethasone—systemic lupus erythematosus	7.79e-05	0.00133	CcSEcCtD
Metoclopramide—Diarrhoea—Cyclosporine—systemic lupus erythematosus	7.76e-05	0.00133	CcSEcCtD
Metoclopramide—CYP2D6—central nervous system—systemic lupus erythematosus	7.69e-05	0.0108	CbGeAlD
Metoclopramide—Hypersensitivity—Prednisolone—systemic lupus erythematosus	7.61e-05	0.0013	CcSEcCtD
Metoclopramide—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	7.57e-05	0.00129	CcSEcCtD
Metoclopramide—Urticaria—Triamcinolone—systemic lupus erythematosus	7.54e-05	0.00129	CcSEcCtD
Metoclopramide—Urticaria—Methylprednisolone—systemic lupus erythematosus	7.53e-05	0.00128	CcSEcCtD
Metoclopramide—Body temperature increased—Triamcinolone—systemic lupus erythematosus	7.51e-05	0.00128	CcSEcCtD
Metoclopramide—Dizziness—Cyclosporine—systemic lupus erythematosus	7.5e-05	0.00128	CcSEcCtD
Metoclopramide—Oedema—Prednisone—systemic lupus erythematosus	7.5e-05	0.00128	CcSEcCtD
Metoclopramide—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	7.43e-05	0.00127	CcSEcCtD
Metoclopramide—Fatigue—Dexamethasone—systemic lupus erythematosus	7.43e-05	0.00127	CcSEcCtD
Metoclopramide—Fatigue—Betamethasone—systemic lupus erythematosus	7.43e-05	0.00127	CcSEcCtD
Metoclopramide—Tachycardia—Prednisone—systemic lupus erythematosus	7.32e-05	0.00125	CcSEcCtD
Metoclopramide—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	7.32e-05	0.00125	CcSEcCtD
Metoclopramide—Asthenia—Hydrocortisone—systemic lupus erythematosus	7.24e-05	0.00123	CcSEcCtD
Metoclopramide—Rash—Cyclosporine—systemic lupus erythematosus	7.15e-05	0.00122	CcSEcCtD
Metoclopramide—Dermatitis—Cyclosporine—systemic lupus erythematosus	7.15e-05	0.00122	CcSEcCtD
Metoclopramide—Headache—Cyclosporine—systemic lupus erythematosus	7.11e-05	0.00121	CcSEcCtD
Metoclopramide—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	7.1e-05	0.00121	CcSEcCtD
Metoclopramide—Feeling abnormal—Betamethasone—systemic lupus erythematosus	7.1e-05	0.00121	CcSEcCtD
Metoclopramide—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	7e-05	0.00119	CcSEcCtD
Metoclopramide—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	6.98e-05	0.00119	CcSEcCtD
Metoclopramide—Rash—Mycophenolate mofetil—systemic lupus erythematosus	6.98e-05	0.00119	CcSEcCtD
Metoclopramide—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	6.97e-05	0.00119	CcSEcCtD
Metoclopramide—Headache—Mycophenolate mofetil—systemic lupus erythematosus	6.93e-05	0.00118	CcSEcCtD
Metoclopramide—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	6.9e-05	0.00118	CcSEcCtD
Metoclopramide—Leukopenia—Methotrexate—systemic lupus erythematosus	6.88e-05	0.00117	CcSEcCtD
Metoclopramide—Urticaria—Betamethasone—systemic lupus erythematosus	6.84e-05	0.00117	CcSEcCtD
Metoclopramide—Urticaria—Dexamethasone—systemic lupus erythematosus	6.84e-05	0.00117	CcSEcCtD
Metoclopramide—Dizziness—Prednisolone—systemic lupus erythematosus	6.83e-05	0.00117	CcSEcCtD
Metoclopramide—Asthenia—Triamcinolone—systemic lupus erythematosus	6.81e-05	0.00116	CcSEcCtD
Metoclopramide—Body temperature increased—Betamethasone—systemic lupus erythematosus	6.81e-05	0.00116	CcSEcCtD
Metoclopramide—Body temperature increased—Dexamethasone—systemic lupus erythematosus	6.81e-05	0.00116	CcSEcCtD
Metoclopramide—Asthenia—Methylprednisolone—systemic lupus erythematosus	6.8e-05	0.00116	CcSEcCtD
Metoclopramide—Insomnia—Prednisone—systemic lupus erythematosus	6.79e-05	0.00116	CcSEcCtD
Metoclopramide—Nausea—Cyclosporine—systemic lupus erythematosus	6.74e-05	0.00115	CcSEcCtD
Metoclopramide—Dizziness—Hydrocortisone—systemic lupus erythematosus	6.67e-05	0.00114	CcSEcCtD
Metoclopramide—Convulsion—Methotrexate—systemic lupus erythematosus	6.66e-05	0.00114	CcSEcCtD
Metoclopramide—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	6.57e-05	0.00112	CcSEcCtD
Metoclopramide—Rash—Prednisolone—systemic lupus erythematosus	6.51e-05	0.00111	CcSEcCtD
Metoclopramide—Dermatitis—Prednisolone—systemic lupus erythematosus	6.5e-05	0.00111	CcSEcCtD
Metoclopramide—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	6.48e-05	0.00111	CcSEcCtD
Metoclopramide—Fatigue—Prednisone—systemic lupus erythematosus	6.47e-05	0.0011	CcSEcCtD
Metoclopramide—Headache—Prednisolone—systemic lupus erythematosus	6.47e-05	0.0011	CcSEcCtD
Metoclopramide—Rash—Hydrocortisone—systemic lupus erythematosus	6.36e-05	0.00109	CcSEcCtD
Metoclopramide—Dermatitis—Hydrocortisone—systemic lupus erythematosus	6.35e-05	0.00108	CcSEcCtD
Metoclopramide—Confusional state—Methotrexate—systemic lupus erythematosus	6.32e-05	0.00108	CcSEcCtD
Metoclopramide—Headache—Hydrocortisone—systemic lupus erythematosus	6.32e-05	0.00108	CcSEcCtD
Metoclopramide—Dizziness—Triamcinolone—systemic lupus erythematosus	6.28e-05	0.00107	CcSEcCtD
Metoclopramide—Dizziness—Methylprednisolone—systemic lupus erythematosus	6.26e-05	0.00107	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisone—systemic lupus erythematosus	6.18e-05	0.00106	CcSEcCtD
Metoclopramide—Asthenia—Betamethasone—systemic lupus erythematosus	6.18e-05	0.00106	CcSEcCtD
Metoclopramide—Asthenia—Dexamethasone—systemic lupus erythematosus	6.18e-05	0.00106	CcSEcCtD
Metoclopramide—Nausea—Prednisolone—systemic lupus erythematosus	6.13e-05	0.00105	CcSEcCtD
Metoclopramide—Nausea—Hydrocortisone—systemic lupus erythematosus	5.99e-05	0.00102	CcSEcCtD
Metoclopramide—Rash—Triamcinolone—systemic lupus erythematosus	5.99e-05	0.00102	CcSEcCtD
Metoclopramide—Dermatitis—Triamcinolone—systemic lupus erythematosus	5.98e-05	0.00102	CcSEcCtD
Metoclopramide—Rash—Methylprednisolone—systemic lupus erythematosus	5.97e-05	0.00102	CcSEcCtD
Metoclopramide—Dermatitis—Methylprednisolone—systemic lupus erythematosus	5.97e-05	0.00102	CcSEcCtD
Metoclopramide—Urticaria—Prednisone—systemic lupus erythematosus	5.96e-05	0.00102	CcSEcCtD
Metoclopramide—Headache—Triamcinolone—systemic lupus erythematosus	5.95e-05	0.00102	CcSEcCtD
Metoclopramide—Headache—Methylprednisolone—systemic lupus erythematosus	5.94e-05	0.00101	CcSEcCtD
Metoclopramide—Body temperature increased—Prednisone—systemic lupus erythematosus	5.93e-05	0.00101	CcSEcCtD
Metoclopramide—Diarrhoea—Dexamethasone—systemic lupus erythematosus	5.89e-05	0.00101	CcSEcCtD
Metoclopramide—Diarrhoea—Betamethasone—systemic lupus erythematosus	5.89e-05	0.00101	CcSEcCtD
Metoclopramide—Hypotension—Methotrexate—systemic lupus erythematosus	5.86e-05	0.001	CcSEcCtD
Metoclopramide—Dizziness—Dexamethasone—systemic lupus erythematosus	5.7e-05	0.000972	CcSEcCtD
Metoclopramide—Dizziness—Betamethasone—systemic lupus erythematosus	5.7e-05	0.000972	CcSEcCtD
Metoclopramide—Insomnia—Methotrexate—systemic lupus erythematosus	5.67e-05	0.000968	CcSEcCtD
Metoclopramide—Nausea—Triamcinolone—systemic lupus erythematosus	5.64e-05	0.000963	CcSEcCtD
Metoclopramide—Nausea—Methylprednisolone—systemic lupus erythematosus	5.63e-05	0.000961	CcSEcCtD
Metoclopramide—Dyspnoea—Methotrexate—systemic lupus erythematosus	5.59e-05	0.000954	CcSEcCtD
Metoclopramide—Somnolence—Methotrexate—systemic lupus erythematosus	5.57e-05	0.000952	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisone—systemic lupus erythematosus	5.53e-05	0.000944	CcSEcCtD
Metoclopramide—Rash—Dexamethasone—systemic lupus erythematosus	5.43e-05	0.000927	CcSEcCtD
Metoclopramide—Rash—Betamethasone—systemic lupus erythematosus	5.43e-05	0.000927	CcSEcCtD
Metoclopramide—Dermatitis—Dexamethasone—systemic lupus erythematosus	5.43e-05	0.000926	CcSEcCtD
Metoclopramide—Dermatitis—Betamethasone—systemic lupus erythematosus	5.43e-05	0.000926	CcSEcCtD
Metoclopramide—Fatigue—Methotrexate—systemic lupus erythematosus	5.41e-05	0.000923	CcSEcCtD
Metoclopramide—Headache—Dexamethasone—systemic lupus erythematosus	5.4e-05	0.000921	CcSEcCtD
Metoclopramide—Headache—Betamethasone—systemic lupus erythematosus	5.4e-05	0.000921	CcSEcCtD
Metoclopramide—Asthenia—Prednisone—systemic lupus erythematosus	5.38e-05	0.000919	CcSEcCtD
Metoclopramide—Feeling abnormal—Methotrexate—systemic lupus erythematosus	5.17e-05	0.000882	CcSEcCtD
Metoclopramide—Diarrhoea—Prednisone—systemic lupus erythematosus	5.13e-05	0.000876	CcSEcCtD
Metoclopramide—Nausea—Betamethasone—systemic lupus erythematosus	5.12e-05	0.000874	CcSEcCtD
Metoclopramide—Nausea—Dexamethasone—systemic lupus erythematosus	5.12e-05	0.000874	CcSEcCtD
Metoclopramide—Urticaria—Methotrexate—systemic lupus erythematosus	4.98e-05	0.00085	CcSEcCtD
Metoclopramide—Dizziness—Prednisone—systemic lupus erythematosus	4.96e-05	0.000847	CcSEcCtD
Metoclopramide—Body temperature increased—Methotrexate—systemic lupus erythematosus	4.96e-05	0.000846	CcSEcCtD
Metoclopramide—Rash—Prednisone—systemic lupus erythematosus	4.73e-05	0.000808	CcSEcCtD
Metoclopramide—Dermatitis—Prednisone—systemic lupus erythematosus	4.73e-05	0.000807	CcSEcCtD
Metoclopramide—Headache—Prednisone—systemic lupus erythematosus	4.7e-05	0.000802	CcSEcCtD
Metoclopramide—Hypersensitivity—Methotrexate—systemic lupus erythematosus	4.62e-05	0.000789	CcSEcCtD
Metoclopramide—Asthenia—Methotrexate—systemic lupus erythematosus	4.5e-05	0.000768	CcSEcCtD
Metoclopramide—Nausea—Prednisone—systemic lupus erythematosus	4.46e-05	0.000761	CcSEcCtD
Metoclopramide—Diarrhoea—Methotrexate—systemic lupus erythematosus	4.29e-05	0.000732	CcSEcCtD
Metoclopramide—Dizziness—Methotrexate—systemic lupus erythematosus	4.15e-05	0.000708	CcSEcCtD
Metoclopramide—Rash—Methotrexate—systemic lupus erythematosus	3.95e-05	0.000675	CcSEcCtD
Metoclopramide—Dermatitis—Methotrexate—systemic lupus erythematosus	3.95e-05	0.000674	CcSEcCtD
Metoclopramide—Headache—Methotrexate—systemic lupus erythematosus	3.93e-05	0.000671	CcSEcCtD
Metoclopramide—Nausea—Methotrexate—systemic lupus erythematosus	3.72e-05	0.000636	CcSEcCtD
Metoclopramide—DRD2—G alpha (i) signalling events—C3—systemic lupus erythematosus	7.6e-06	0.00171	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	7.54e-06	0.00169	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.46e-06	0.00167	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—F2—systemic lupus erythematosus	7.42e-06	0.00167	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—JUNB—systemic lupus erythematosus	7.32e-06	0.00164	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.31e-06	0.00164	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	7.31e-06	0.00164	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	7.22e-06	0.00162	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	7.07e-06	0.00159	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	7.01e-06	0.00157	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.01e-06	0.00157	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—PPARG—systemic lupus erythematosus	6.99e-06	0.00157	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—RASGRP1—systemic lupus erythematosus	6.95e-06	0.00156	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	6.93e-06	0.00156	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CXCL12—systemic lupus erythematosus	6.87e-06	0.00154	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—P2RY12—systemic lupus erythematosus	6.85e-06	0.00154	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—PPARG—systemic lupus erythematosus	6.84e-06	0.00153	CbGpPWpGaD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.8e-06	0.00153	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PRL—systemic lupus erythematosus	6.74e-06	0.00151	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	6.73e-06	0.00151	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.61e-06	0.00148	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.55e-06	0.00147	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.4e-06	0.00144	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	6.3e-06	0.00141	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	6.19e-06	0.00139	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	6.18e-06	0.00139	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CCR5—systemic lupus erythematosus	6.16e-06	0.00138	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	6.05e-06	0.00136	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	6.04e-06	0.00136	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—C3—systemic lupus erythematosus	6.02e-06	0.00135	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.01e-06	0.00135	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—EP300—systemic lupus erythematosus	5.97e-06	0.00134	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	5.92e-06	0.00133	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.89e-06	0.00132	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	5.77e-06	0.0013	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—RXRA—systemic lupus erythematosus	5.74e-06	0.00129	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	5.68e-06	0.00127	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	5.65e-06	0.00127	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.51e-06	0.00124	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.5e-06	0.00124	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—JAK1—systemic lupus erythematosus	5.39e-06	0.00121	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.32e-06	0.00119	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	5.31e-06	0.00119	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—F2—systemic lupus erythematosus	5.28e-06	0.00119	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—P2RY12—systemic lupus erythematosus	5.24e-06	0.00118	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	5.19e-06	0.00117	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.16e-06	0.00116	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	5.13e-06	0.00115	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CCR5—systemic lupus erythematosus	5.11e-06	0.00115	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	5.08e-06	0.00114	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.04e-06	0.00113	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL2—systemic lupus erythematosus	5e-06	0.00112	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—C3—systemic lupus erythematosus	4.99e-06	0.00112	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—RXRA—systemic lupus erythematosus	4.94e-06	0.00111	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	4.73e-06	0.00106	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	4.73e-06	0.00106	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CCR5—systemic lupus erythematosus	4.71e-06	0.00106	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CCL2—systemic lupus erythematosus	4.71e-06	0.00106	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	4.63e-06	0.00104	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—RXRA—systemic lupus erythematosus	4.62e-06	0.00104	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CCR5—systemic lupus erythematosus	4.61e-06	0.00103	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCL12—systemic lupus erythematosus	4.61e-06	0.00103	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—C3—systemic lupus erythematosus	4.6e-06	0.00103	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.58e-06	0.00103	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—EP300—systemic lupus erythematosus	4.57e-06	0.00103	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—C3—systemic lupus erythematosus	4.5e-06	0.00101	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—EP300—systemic lupus erythematosus	4.47e-06	0.001	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—F2—systemic lupus erythematosus	4.38e-06	0.000984	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	4.3e-06	0.000965	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.29e-06	0.000962	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CD80—systemic lupus erythematosus	4.2e-06	0.000943	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TLR9—systemic lupus erythematosus	4.18e-06	0.000938	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—P2RY12—systemic lupus erythematosus	4.05e-06	0.000908	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—F2—systemic lupus erythematosus	4.04e-06	0.000907	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—F2—systemic lupus erythematosus	3.95e-06	0.000888	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—IL6—systemic lupus erythematosus	3.91e-06	0.000878	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CCL2—systemic lupus erythematosus	3.91e-06	0.000877	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	3.88e-06	0.000872	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	3.82e-06	0.000858	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	3.8e-06	0.000853	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CSK—systemic lupus erythematosus	3.72e-06	0.000836	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—JAK1—systemic lupus erythematosus	3.67e-06	0.000824	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	3.62e-06	0.000813	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PPARG—systemic lupus erythematosus	3.62e-06	0.000813	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CCL2—systemic lupus erythematosus	3.6e-06	0.000808	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TYK2—systemic lupus erythematosus	3.55e-06	0.000796	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	3.54e-06	0.000796	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	3.53e-06	0.000792	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CCL2—systemic lupus erythematosus	3.52e-06	0.000791	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NOS3—systemic lupus erythematosus	3.48e-06	0.000782	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CCR5—systemic lupus erythematosus	3.48e-06	0.000781	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	3.45e-06	0.000775	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	3.43e-06	0.000769	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NCF2—systemic lupus erythematosus	3.41e-06	0.000764	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—C3—systemic lupus erythematosus	3.4e-06	0.000763	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—LYN—systemic lupus erythematosus	3.38e-06	0.000759	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.33e-06	0.000748	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.32e-06	0.000745	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	3.29e-06	0.000738	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ALB—systemic lupus erythematosus	3.26e-06	0.000731	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	3.22e-06	0.000722	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TLR9—systemic lupus erythematosus	3.2e-06	0.000718	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCR5—systemic lupus erythematosus	3.16e-06	0.000709	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TLR9—systemic lupus erythematosus	3.13e-06	0.000702	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PPARG—systemic lupus erythematosus	3.12e-06	0.0007	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—NOS3—systemic lupus erythematosus	3.11e-06	0.000699	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL2RA—systemic lupus erythematosus	3.11e-06	0.000699	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—P2RY12—systemic lupus erythematosus	3.1e-06	0.000695	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—C3—systemic lupus erythematosus	3.09e-06	0.000693	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—P2RY12—systemic lupus erythematosus	3.03e-06	0.00068	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.02e-06	0.000677	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—IL6—systemic lupus erythematosus	2.99e-06	0.000672	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—F2—systemic lupus erythematosus	2.98e-06	0.00067	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL2—systemic lupus erythematosus	2.95e-06	0.000663	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL6—systemic lupus erythematosus	2.94e-06	0.000659	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—IL6—systemic lupus erythematosus	2.93e-06	0.000658	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.92e-06	0.000656	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PPARG—systemic lupus erythematosus	2.92e-06	0.000655	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.86e-06	0.000642	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CSK—systemic lupus erythematosus	2.85e-06	0.00064	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PTGS2—systemic lupus erythematosus	2.85e-06	0.000639	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	2.81e-06	0.00063	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ALB—systemic lupus erythematosus	2.81e-06	0.00063	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MMP9—systemic lupus erythematosus	2.79e-06	0.000627	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CSK—systemic lupus erythematosus	2.79e-06	0.000626	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.78e-06	0.000625	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	2.78e-06	0.000623	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	2.75e-06	0.000617	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.72e-06	0.000611	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—F2—systemic lupus erythematosus	2.71e-06	0.000608	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—NOS3—systemic lupus erythematosus	2.68e-06	0.000602	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—JUNB—systemic lupus erythematosus	2.67e-06	0.0006	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	2.66e-06	0.000597	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—EP300—systemic lupus erythematosus	2.65e-06	0.000595	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ALB—systemic lupus erythematosus	2.62e-06	0.000589	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	2.62e-06	0.000589	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NCF2—systemic lupus erythematosus	2.61e-06	0.000585	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	2.6e-06	0.000585	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—C3—systemic lupus erythematosus	2.6e-06	0.000584	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—LYN—systemic lupus erythematosus	2.59e-06	0.000581	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	2.57e-06	0.000576	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—JAK1—systemic lupus erythematosus	2.55e-06	0.000573	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NCF2—systemic lupus erythematosus	2.55e-06	0.000572	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—C3—systemic lupus erythematosus	2.55e-06	0.000571	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.54e-06	0.00057	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.54e-06	0.00057	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—LYN—systemic lupus erythematosus	2.53e-06	0.000569	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—NOS3—systemic lupus erythematosus	2.51e-06	0.000563	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.51e-06	0.000563	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—JAK1—systemic lupus erythematosus	2.5e-06	0.00056	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.49e-06	0.000558	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PRL—systemic lupus erythematosus	2.46e-06	0.000553	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PTGS2—systemic lupus erythematosus	2.45e-06	0.000551	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.42e-06	0.000543	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.42e-06	0.000542	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.38e-06	0.000535	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—EP300—systemic lupus erythematosus	2.37e-06	0.000532	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.37e-06	0.000531	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—C3—systemic lupus erythematosus	2.36e-06	0.00053	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.33e-06	0.000523	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—C3—systemic lupus erythematosus	2.31e-06	0.000519	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.3e-06	0.000517	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PTGS2—systemic lupus erythematosus	2.3e-06	0.000515	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—F2—systemic lupus erythematosus	2.28e-06	0.000513	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—F2—systemic lupus erythematosus	2.23e-06	0.000502	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	2.23e-06	0.000501	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.19e-06	0.000492	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.08e-06	0.000468	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—F2—systemic lupus erythematosus	2.07e-06	0.000465	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—JUNB—systemic lupus erythematosus	2.04e-06	0.000459	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—EP300—systemic lupus erythematosus	2.04e-06	0.000458	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.04e-06	0.000458	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—F2—systemic lupus erythematosus	2.03e-06	0.000456	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.01e-06	0.000451	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—JUNB—systemic lupus erythematosus	2e-06	0.000449	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—JAK1—systemic lupus erythematosus	1.97e-06	0.000442	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.94e-06	0.000436	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—EP300—systemic lupus erythematosus	1.91e-06	0.000429	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.9e-06	0.000427	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PRL—systemic lupus erythematosus	1.88e-06	0.000423	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCR5—systemic lupus erythematosus	1.87e-06	0.000419	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.85e-06	0.000415	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PRL—systemic lupus erythematosus	1.84e-06	0.000414	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.84e-06	0.000413	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL2—systemic lupus erythematosus	1.83e-06	0.00041	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—C3—systemic lupus erythematosus	1.82e-06	0.000409	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.81e-06	0.000406	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL6—systemic lupus erythematosus	1.74e-06	0.00039	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.68e-06	0.000377	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.64e-06	0.000369	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—F2—systemic lupus erythematosus	1.6e-06	0.000359	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.54e-06	0.000345	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CD80—systemic lupus erythematosus	1.53e-06	0.000345	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—JAK1—systemic lupus erythematosus	1.51e-06	0.000338	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.51e-06	0.000338	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.47e-06	0.000331	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCR5—systemic lupus erythematosus	1.43e-06	0.00032	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL2—systemic lupus erythematosus	1.43e-06	0.00032	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.41e-06	0.000316	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.4e-06	0.000314	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL2—systemic lupus erythematosus	1.4e-06	0.000313	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—C3—systemic lupus erythematosus	1.4e-06	0.000313	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.38e-06	0.000309	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL2—systemic lupus erythematosus	1.37e-06	0.000307	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—C3—systemic lupus erythematosus	1.37e-06	0.000307	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TYK2—systemic lupus erythematosus	1.3e-06	0.000291	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NOS3—systemic lupus erythematosus	1.27e-06	0.000285	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	1.25e-06	0.000281	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—F2—systemic lupus erythematosus	1.23e-06	0.000275	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—F2—systemic lupus erythematosus	1.2e-06	0.000269	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CD80—systemic lupus erythematosus	1.17e-06	0.000264	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CD80—systemic lupus erythematosus	1.15e-06	0.000258	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.1e-06	0.000247	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL2—systemic lupus erythematosus	1.09e-06	0.000245	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL2—systemic lupus erythematosus	1.08e-06	0.000242	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6—systemic lupus erythematosus	1.07e-06	0.000241	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.07e-06	0.00024	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MMP9—systemic lupus erythematosus	1.02e-06	0.000229	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.02e-06	0.000228	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TYK2—systemic lupus erythematosus	9.91e-07	0.000223	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NOS3—systemic lupus erythematosus	9.73e-07	0.000218	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TYK2—systemic lupus erythematosus	9.7e-07	0.000218	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—EP300—systemic lupus erythematosus	9.67e-07	0.000217	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NOS3—systemic lupus erythematosus	9.52e-07	0.000214	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—VEGFA—systemic lupus erythematosus	9.16e-07	0.000206	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.43e-07	0.000189	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TGFB1—systemic lupus erythematosus	8.41e-07	0.000189	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.25e-07	0.000185	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL2—systemic lupus erythematosus	8.25e-07	0.000185	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6—systemic lupus erythematosus	8.21e-07	0.000184	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL2—systemic lupus erythematosus	8.07e-07	0.000181	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6—systemic lupus erythematosus	8.03e-07	0.00018	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	7.89e-07	0.000177	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MMP9—systemic lupus erythematosus	7.81e-07	0.000175	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.78e-07	0.000175	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MMP9—systemic lupus erythematosus	7.64e-07	0.000172	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.61e-07	0.000171	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—EP300—systemic lupus erythematosus	7.4e-07	0.000166	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—EP300—systemic lupus erythematosus	7.25e-07	0.000163	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	7.1e-07	0.000159	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—VEGFA—systemic lupus erythematosus	7.01e-07	0.000157	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.86e-07	0.000154	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	6.79e-07	0.000152	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.44e-07	0.000144	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6—systemic lupus erythematosus	6.34e-07	0.000142	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.3e-07	0.000141	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	6.21e-07	0.000139	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	5.16e-07	0.000116	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6—systemic lupus erythematosus	4.85e-07	0.000109	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6—systemic lupus erythematosus	4.75e-07	0.000107	CbGpPWpGaD
